Concepedia

Dirk Finsinger

DF

14

Publications

1.3K

Citations

14

H-Index

1995

Active since

Affiliations

Merck (Germany)(Current)

Technical University of Munich

University of Salerno

Orion Corporation (Finland)

University of Tübingen

Dirk Finsinger is an author at Merck (Germany) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1995–2021

14

Publications

14

Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the α<sub>v</sub>β<sub>3</sub> Integrin for a New Cancer Therapy

Roland Haubner, Dirk Finsinger, Horst Kessler · Angewandte Chemie International Edition in English · 1997 · 428 citations

, , +23

Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation

Martin Kantlehner, Patricia Schaffner, Dirk Finsinger et al. · ChemBioChem · 2000 · 312 citations

Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery

Dirk Finsinger, Jean-Serge Rémy, Patrick Erbacher et al. · Gene Therapy · 2000 · 147 citations

, , +8

Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants

Martin Kantlehner, Dirk Finsinger, J. Meyer et al. · Angewandte Chemie International Edition · 1999 · 119 citations

, , +14

The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5

Kai Schiemann, Dirk Finsinger, Frank T. Zenke et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 63 citations · Full text

, , +8

Rows per page

1–5 of 14